BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33949000)

  • 1. Prevalence of leucocyte antibodies in non-transfused male and female platelet apheresis donors.
    Simtong P; Sudwilai Y; Cheunta S; Leelayuwat C; Romphruk AV
    Transfus Med; 2021 Jun; 31(3):186-192. PubMed ID: 33949000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of leucocyte alloantibodies in blood donors from South China.
    Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
    Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
    De Clippel D; Baeten M; Torfs A; Emonds MP; Feys HB; Compernolle V; Vandekerckhove P
    Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
    Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
    Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neutrophil antibodies in a blood donor population: a lookback study.
    Gottschall J; Triulzi D; Kakaiya R; Carrick D; Roback JD; Carey P; Kleinman S;
    Vox Sang; 2013 Feb; 104(2):166-70. PubMed ID: 22998453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
    Jug R; Anani W; Callum J
    Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
    Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
    Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
    Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
    Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome.
    Quillen K; Medrano C; Adams S; Peterson B; Hackett J; Leitman SF; Klein HG; Stroncek DF
    Transfusion; 2011 Mar; 51(3):504-10. PubMed ID: 20849407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies.
    Fadeyi EA; Adams S; Sheldon S; Leitman SF; Wesley R; Klein HG; Stroncek DF
    Vox Sang; 2008 May; 94(4):324-8. PubMed ID: 18282262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors.
    Kakaiya RM; Triulzi DJ; Wright DJ; Steele WR; Kleinman SH; Busch MP; Norris PJ; Hillyer CD; Gottschall JL; Rios JA; Carey P; Glynn SA;
    Transfusion; 2010 Jun; 50(6):1328-34. PubMed ID: 20070615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we underestimating reverse TRALI?
    De Clippel D; Emonds MP; Compernolle V
    Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-related acute lung injury: current concepts for the clinician.
    Triulzi DJ
    Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency and specificity of human neutrophil antigen antibodies in a blood donor population.
    Gottschall JL; Triulzi DJ; Curtis B; Kakaiya RM; Busch MP; Norris PJ; Glynn SA; Carrick D; Wright DJ; Kleinman S;
    Transfusion; 2011 Apr; 51(4):820-7. PubMed ID: 20977484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte antibodies in male blood donors: can they trigger transfusion-related acute lung injury?
    Nguyen XD; Schulze TJ; Bugert P; Lauber-Härtl S; Schulz-Linkholt M; González-Schulze K; Reil A; Dengler T; Panzer S; Seifried E
    Transfusion; 2018 Aug; 58(8):1894-1901. PubMed ID: 29707799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure.
    Rios JA; Schlumpf KS; Kakaiya RM; Triulzi DJ; Roback JD; Kleinman SH; Murphy EL; Gottschall JL; Carey PM;
    Transfusion; 2011 Jun; 51(6):1197-206. PubMed ID: 21182532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing assay cutoffs for HLA antibody screening of apheresis donors.
    Carrick DM; Norris PJ; Endres RO; Pandey S; Kleinman SH; Wright D; Sun Y; Busch MP;
    Transfusion; 2011 Oct; 51(10):2092-101. PubMed ID: 21332726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.